Skip to main content

Pradaxa Bleeding Risk

Pradaxa bleeding risk

Known generically as dabigatran etexilate, Pradaxa is an anticoagulant medication manufactured by Boehringer Ingelheim. Pradaxa gained U.S. Food and Drug Administration (FDA) approval in 2010 to lower the risk of blood clots and strokes in patients diagnosed with non-valvular atrial fibrillation.

In November 2012, the FDA released a safety announcement about Pradaxa and the increased risk of serious bleeding episodes associated with use of the drug. In the announcement, the FDA noted that, following Pradaxa approval, they began receiving a large number of adverse event reports about Pradaxa bleeding.

To further explore these Pradaxa bleeding events, the FDA conducted its own research into the matter, and discovered that the Pradaxa bleeding risk, when compared to an older anticoagulant warfarin, are similar. However, Pradaxa was marketed as an updated version of warfarin, one that would require less monitoring and doctor’s visits. As the FDA’s results demonstrate, Pradaxa is not, in fact, a superior version of warfarin.

In fact, while warfarin does have a known cure for patients suffering from a serious bleeding episode, such a cure does not yet exist for Pradaxa, which makes this medication all the more riskier for patients to use.

Pradaxa Bleeding Risk

When using Pradaxa, there are several signs that may alert patients that they could experience a more serious bleeding episode. It is important to notice abnormal gum or nose bleeding, heavier than normal vaginal and menstrual bleeding, blood in the urine, vomit or stools, and unusual bruising. It is important to see the prescribing physician if any of these bleeding signs begin to surface.

Carey Danis & Lowe is Here to Help

If you believe that you were injured by Pradaxa, Carey Danis & Lowe is available to assist you in seeking legal recourse. Discuss your case and legal options with a Carey Danis & Lowe Pradaxa lawyer. Our initial consultations are free.

Carey Danis & Lowe Pradaxa lawyers are highly experienced in handling personal injury claims and pharmaceutical litigation involving defective drugs. We work closely alongside our team of medical experts, on-staff nurses, and our clients to develop strong court cases.

For more information about Pradaxa bleeding risks, and for assistance with filing a Pradaxa bleeding lawsuit, contact Carey Danis & Lowe by phone at 800.721.2519, or by completing a confidential personal injury claim.

Stay up-to-date on the latest personal injury litigation news and Pradaxa bleeding lawsuits by reading the Carey Danis & Lowe blog.